Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs TYCHE INDUSTRIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS TYCHE INDUSTRIES DECIPHER LABS/
TYCHE INDUSTRIES
 
P/E (TTM) x -2.1 12.6 - View Chart
P/BV x 0.6 1.5 41.7% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 DECIPHER LABS   TYCHE INDUSTRIES
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
TYCHE INDUSTRIES
Mar-23
DECIPHER LABS/
TYCHE INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs63163 38.7%   
Low Rs14105 13.4%   
Sales per share (Unadj.) Rs45.173.5 61.4%  
Earnings per share (Unadj.) Rs-2.713.8 -19.2%  
Cash flow per share (Unadj.) Rs-2.215.6 -14.4%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs23.0113.9 20.2%  
Shares outstanding (eoy) m10.1010.25 98.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.8 46.9%   
Avg P/E ratio x-14.59.7 -149.8%  
P/CF ratio (eoy) x-17.38.6 -200.5%  
Price / Book Value ratio x1.71.2 142.6%  
Dividend payout %014.5 -0.0%   
Avg Mkt Cap Rs m3891,372 28.4%   
No. of employees `000NANA-   
Total wages/salary Rs m41270 591.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m456754 60.5%  
Other income Rs m7448 152.7%   
Total revenues Rs m529802 66.0%   
Gross profit Rs m-106160 -66.3%  
Depreciation Rs m418 24.1%   
Interest Rs m50 48,200.0%   
Profit before tax Rs m-42191 -21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1549 -30.1%   
Profit after tax Rs m-27142 -18.9%  
Gross profit margin %-23.321.3 -109.6%  
Effective tax rate %35.525.7 138.0%   
Net profit margin %-5.918.8 -31.3%  
BALANCE SHEET DATA
Current assets Rs m2011,219 16.5%   
Current liabilities Rs m50210 23.6%   
Net working cap to sales %33.2133.9 24.8%  
Current ratio x4.15.8 69.7%  
Inventory Days Days3013 239.6%  
Debtors Days Days7891,069 73.8%  
Net fixed assets Rs m71192 36.8%   
Share capital Rs m101102 98.6%   
"Free" reserves Rs m1311,065 12.3%   
Net worth Rs m2321,168 19.9%   
Long term debt Rs m00-   
Total assets Rs m2721,411 19.2%  
Interest coverage x-7.619,085.0 -0.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.70.5 314.1%   
Return on assets %-8.110.0 -80.7%  
Return on equity %-11.612.1 -95.2%  
Return on capital %-15.816.3 -96.9%  
Exports to sales %057.9 0.0%   
Imports to sales %019.9 0.0%   
Exports (fob) Rs mNA437 0.0%   
Imports (cif) Rs mNA150 0.0%   
Fx inflow Rs m0437 0.0%   
Fx outflow Rs m0161 0.0%   
Net fx Rs m0275 0.0%   
CASH FLOW
From Operations Rs m-1668 -22.9%  
From Investments Rs m-4319 -220.2%  
From Financial Activity Rs m-22-15 140.0%  
Net Cashflow Rs m-8072 -110.6%  

Share Holding

Indian Promoters % 0.0 62.0 -  
Foreign collaborators % 16.4 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 38.0 219.7%  
Shareholders   34,511 8,221 419.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on COMBAT DRUGS vs TYCHE INDUSTRIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs TYCHE INDUSTRIES Share Price Performance

Period COMBAT DRUGS TYCHE INDUSTRIES S&P BSE HEALTHCARE
1-Day 0.68% -1.01% 1.18%
1-Month -17.62% -3.49% -0.75%
1-Year -1.07% 29.01% 61.82%
3-Year CAGR -24.12% -1.02% 18.16%
5-Year CAGR -10.83% 20.25% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the TYCHE INDUSTRIES share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of TYCHE INDUSTRIES the stake stands at 62.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of TYCHE INDUSTRIES.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

TYCHE INDUSTRIES paid Rs 2.0, and its dividend payout ratio stood at 14.5%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of TYCHE INDUSTRIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.